Alan A. Ades insider trades
Open-market stock purchases and sales by Alan A. Ades, Director, 10% Owner at Organogenesis Holdings Inc, from SEC Form 4 filings since Dec 10, 2018.
Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -41%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- ORGO Organogenesis Holdings Inc: 7 buys, 2 sales, last Jan 9, 2025